Hepatitis C: all 2,356 studies
Page 17 of 24. Open to participants first (101), then studies with results posted, then the rest; newest registration first within each.
- Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV InfectionStatus unknownNCT01718834Phase 1/2
- Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) TherapyCompletedNCT01718158Phase 3
- A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV SubjectsCompletedNCT01718145Phase 3
- Hepatitis C Treatment in Underserved PopulationsStatus unknownNCT01717560Not applicable
- Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE StudiesCompletedNCT01715779
- The Role of FGL2-FcgammaRIIB Inhibitory Pathway in Human Viral HepatitisCompletedNCT01711164
- Pharmacokinetic Study of BMS-914143 in Participants With Normal Renal Function and Mild, Moderate, Severe and End-stage Renal DysfunctionCompletedNCT01708889Phase 1
- The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationCompletedNCT01707849Phase 3
- Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected PatientsCompletedNCT01701336Phase 1
- SIMpill Medication Dispensing Device in the Treatment of HCVWithdrawnNCT01691235
- Randomized Controlled Open Label Trial of Peg Alpha 2a Interferon and Adjusted-dose of Ribavirin vs. Standard Therapy in the Treatment of Naive Chronic Hepatitis C Patients Infected With Genotype 4CompletedNCT01686789Phase 4
- Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive PatientsCompletedNCT01684787Phase 4
- 36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8Status unknownNCT01683786Phase 4
- Improving Blood Safety and HIV Testing in BrazilCompletedNCT01681420Not applicable
- An Observational Study of Pegasys in Dual- or Triple-Therapy in Patients With Chronic Hepatitis CCompletedNCT01679834
- An Observational Study To Assess Liver Fibrosis Stages in Patients With Chronic Hepatitis C InfectionCompletedNCT01671046
- Effects of Metformin, Pegylated Interferon Alpha and Ribavirin for Chronic Hepatitis C With Insulin ResistanceStatus unknownNCT01664845Phase 2/3
- Vitamin D as an add-on Therapy With Pegylated Interferon and Ribavirin for Chronic Hepatitis cStatus unknownNCT01655966Phase 3
- Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver DiseaseWithdrawnNCT01654939Phase 4
- Boceprevir With Peginterferon Alfa-2b and Ribavirin in the Treatment-naive Patients Infected With Genotype 4 Chronic Hepatitis C InfectionStatus unknownNCT01653236Phase 3
- Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382TerminatedNCT01651767Phase 1
- Hansenula-derived Pegylated Interferon in Treatment of Patients With Chronic Hepatitis CStatus unknownNCT01649245Phase 4
- Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in ChinaCompletedNCT01647191Not applicable
- Drug Interaction Study to Assess the Effect of Co-Administered Miravirsen and Telaprevir in Healthy SubjectsCompletedNCT01646489Phase 1
- Safety and Tolerability of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin for the Treatment of Vietnamese Subjects With Chronic Hepatitis C Genotype 1 (P08599)WithdrawnNCT01641666Phase 3
- Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological MechanismsCompletedNCT01641094
- Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis CTerminatedNCT01639547Not applicable
- Histologic Changes and Noninvasive Assessment in Hepatitis C Patients Treated with Peginterferon Alpha-2a and RibavirinCompletedNCT01634919
- Phase 2b Study of BMS-986094 and Daclatasvir, With or Without Ribavirin for the Treatment of Patients With Chronic Hepatitis CWithdrawnNCT01629732Phase 2
- ANNAPURNA: A Study of The Combination of RO5466731, RO5190591, Ritonavir and Copegus (Ribavirin) With or Without RO5024048 in Patients With Chronic Hepatitis C Who Are Either Treatment-Naïve or Have Previously Experienced a Null Response to Interferon-Based TreatmentCompletedNCT01628094Phase 2
- Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health OutcomesWithdrawnNCT01625793Not applicable
- BIP48 (Peginterferon Alfa 2b 48kDa) Compared With Pegasys® (Peginterferon 2a 40kDa) for Treatment of Chronic Hepatitis CStatus unknownNCT01623336Phase 2/3
- Adult-to-Adult Living Donor Transplant Cohort StudyCompletedNCT01619475
- Safety and Efficacy Study of Pegylated Interferon Lambda With and Without Daclatasvir, Compared to Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C Genotype 2 and 3CompletedNCT01616524Phase 3
- An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver CirrhosisCompletedNCT01609049
- A Phase III Study of BI201335 in Treatment-naive and Prior Relapser Patients With Chronic Hepatitis C InfectionWithdrawnNCT01608737Phase 3
- Pharmacogenomics Study on IL28B Genetic Variants in Chinese Children With Hepatitis C Virus InfectionStatus unknownNCT01607021
- Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV DiseaseCompletedNCT01605513Phase 1/2
- Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver TransplantStatus unknownNCT01603108Phase 2
- Efficacy and Effectiveness of PegInterferon and Ribavirin in Korean Patients With Chronic Hepatitis CCompletedNCT01596517Phase 4
- A 5-year Observational Follow-up Study to Describe Treatment Patterns in Real World of HCV Patients in China.Status unknownNCT01594554
- A Multiple Dose Study to Evaluate the Safety and Efficacy of MK-2748 in Hepatitis C-Infected Participants (MK-2748-002 AM1)CompletedNCT01593735Phase 1
- A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis CCompletedNCT01591668Phase 1
- First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1CompletedNCT01590407Phase 1
- Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034)WithdrawnNCT01590225Phase 3
- Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 InfectionCompletedNCT01587586Phase 2
- A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected PatientsTerminatedNCT01586325Phase 1
- A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody DetectionTerminatedNCT01582594
- Study to Examine Multiple Doses of TMC647055 in Combination With TelaprevirCompletedNCT01582035Phase 1
- Efficacy and Safety Study of Peginterferon Alfa-2b in Chinese Chronic Hepatitis C PatientsCompletedNCT01581398Phase 3
- Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)CompletedNCT01581203Phase 3
- VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis CCompletedNCT01581138Phase 2
- A Study of RO5024048 in Combination With Ritonavir-Boosted Danoprevir and Pegasys/Copegus in Patients With Chronic Hepatitis C Genotype 1 Who Have Failed Prior HCV Protease Inhibitor TreatmentWithdrawnNCT01579019Phase 2
- Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With TelaprevirCompletedNCT01577069
- Phase III Hallmark QUAD: ASV+DCV+Peg+Rib (Nulls/Partials)CompletedNCT01573351Phase 3
- Effects of Activity and Education Program on Patients With Chronic Hepatitis C InfectionStatus unknownNCT01572233Not applicable
- An Efficacy and Safety Study of Telaprevir in Patients With Genotype 1 Hepatitis C Infection After Liver TransplantationCompletedNCT01571583Phase 3
- A Study to Evaluate the Efficacy, Safety and Tolerability of TMC435 in Combination With PegIFN Alfa-2a (Pegasys) and Ribavirin (Copegus) in Treatment-Naïve or Treatment-Experienced, Chronic Hepatitis C Virus Genotype-4 Infected PatientsCompletedNCT01567735Phase 3
- A Pilot Study Evaluating Safety of Sitagliptin Combined With Peg-IFN Alfa-2a + Ribavirin in Chronic Hepatitis C PatientsTerminatedNCT01567540Phase 1
- Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV InfectionTerminatedNCT01560468Phase 1
- A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of MK-8325 in Hepatitis C-Infected Males (MK-8325-002)TerminatedNCT01554189Phase 1
- First in Human Study of ALS-002158; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1TerminatedNCT01554085Phase 1
- A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy VolunteersWithdrawnNCT01549496Phase 1
- Evaluation of Hepatic Pharmacokinetics for Grazoprevir (MK-5172) in Participants With Chronic Hepatitis C (MK-5172-022)WithdrawnNCT01547312Phase 1
- Observational Study of B-Cell Non Hodgkin Lymphomas (NHL) Associated With Hepatitis C Virus (HCV)Status unknownNCT01545544
- Identification of Hepatitis C Virus (HCV) Specific T CellsCompletedNCT01534728
- Three-year Follow-up Study of Subjects Who Participated in a Previous Lambda (BMS-914143) Chronic Hepatitis C Clinical TrialCompletedNCT01525810
- Multiple Ascending Dose Study of BMS-929075 in Hepatitis C Virus (HCV) Infected PatientsWithdrawnNCT01525212Phase 1
- A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected PatientsCompletedNCT01523990Phase 1
- Effect of LEGALON SIL on Hepatitis C Virus Recurrence in Stable Liver Transplanted PatientsTerminatedNCT01518933Phase 2
- 24 VS 48-WEEK TREATMENT WITH PEG-IFN ALPHA-2A IN PATIENTS WITH GENOTYPE 2/3 CHRONIC HEPATITIS CWithdrawnNCT01517308Phase 3
- A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated CirrhosisCompletedNCT01516918Phase 2
- French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and RibavirinCompletedNCT01514890
- An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)CompletedNCT01513941Phase 3
- A Study to Assess the Relative Bioavailability Three New Formulations of Telaprevir in Healthy SubjectsCompletedNCT01511432Phase 1
- Keyhole Limpet Hemocyanin in Chronic Hepatitis CCompletedNCT01509391Not applicable
- Early Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsNo longer availableNCT01508286
- Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)CompletedNCT01508156Phase 1/2
- Telaprevir Open-Label Study in Co-Infected PatientsCompletedNCT01500616Phase 3
- A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) PatientsCompletedNCT01497834Phase 3
- Open-Label Hepatic Impairment StudyCompletedNCT01497327Phase 1
- Role of FXR in Hepatitis C Virus ReplicationTerminatedNCT01492998Not applicable
- Three-year Follow-up Study of Subjects Who Participated in a Previous Asunaprevir (BMS-650032) and/or Daclatasvir (BMS-790052) Chronic Hepatitis C Clinical TrialCompletedNCT01492504
- Psychobiological Characterization of Depression in Hepatitis CStatus unknownNCT01492478
- A Study in Healthy Female Participants Investigating the Effect of TMC435 on the Pharmacokinetics of the Synthetic Hormones of the Oral Contraceptive OvysmenCompletedNCT01486004Phase 1
- A Study of Ritonavir-Boosted Danoprevir and RO5024048 in Different Combinations in Null Responder or Treatment-Naïve Patients With Chronic Hepatitis C and Compensated CirrhosisCompletedNCT01483742Phase 2
- A Study in Healthy Participants Investigating the Safety, Tolerability and Plasma Pharmacokinetics (PK) of Single Oral Doses of JNJ-47910382CompletedNCT01482611Phase 1
- A Study of Mericitabine in Combination With Boceprevir and Pegasys/Copegus in Patients With Chronic Hepatitis CCompletedNCT01482403Phase 2
- A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis CCompletedNCT01482390Phase 2
- A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and TacrolimusCompletedNCT01479881Phase 1
- HCV-TARGET- Hepatitis C Therapeutic Registry and Research NetworkCompletedNCT01474811
- Impact of Cytomegalovirus (CMV) Replication Over Hepatitis C Recurrence in Liver Transplant RecipientsStatus unknownNCT01473849
- Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected SubjectsCompletedNCT01473056Phase 1
- Feasibility of a Hepatitis C Virus (HCV) Decision-Making Intervention Among HIV-infected AdultsCompletedNCT01472354Not applicable
- Pharmacokinetic Study of the HCV Protease Inhibitor Bo-cePRevir and the Proton Pump Inhibitor OMeprazOle (PROMO)CompletedNCT01470690Phase 1
- Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft RecipientsCompletedNCT01469884Phase 4
- Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis CTerminatedNCT01465919Phase 4
- Treating Hispanic Patients Diagnosed With Hepatitis C Using BoceprevirTerminatedNCT01465516
- The Predictive Value of On-treatment Virological Response for Sustained Virological Response in Chronic Hepatitis CCompletedNCT01464008
- Efficacy of PegInterferon-Ribavirin-Boceprevir Therapy in Patients Infected With G1 HCV With Cirrhosis, Awaiting Liver TransplantationCompletedNCT01463956Phase 2